Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.3K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.3K
Antidepressant Drugs: Overview01:25

Antidepressant Drugs: Overview

2.1K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
2.1K
Depression: Overview01:18

Depression: Overview

1.2K
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
1.2K
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.4K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.4K
Long-term Depression01:05

Long-term Depression

27.3K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
27.3K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enduring strengths and a critical gap, the Ottawa Charter and animal rescue fostering in Aotearoa-New Zealand.

Health promotion international·2026
Same author

Why public health practitioners and researchers must stop using the term 'culturally and linguistically diverse (CALD)'.

Public health research & practice·2025
Same author

Public health research priorities of ANZJPH: Findings of our priority setting process.

Australian and New Zealand journal of public health·2025
Same author

Health equity in a climate-altered world.

Australian and New Zealand journal of public health·2025
Same author

Exploring what matters most to patients in relapsed refractory multiple myeloma treatment: a Canadian discrete choice experiment with patients, caregivers and physicians.

BMC cancer·2025
Same author

Welcoming the new ANZJPH editor-in-chief.

Australian and New Zealand journal of public health·2025

Related Experiment Video

Updated: May 6, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.2K

Dietary supplements for preventing postnatal depression.

Brendan J Miller1, Linda Murray, Michael M Beckmann

  • 1Department of Obstetrics and Gynaecology, Flinders Medical Centre, Flinders Drive, Bedford Park, South Australia, Australia, 5042.

The Cochrane Database of Systematic Reviews
|October 26, 2013
PubMed
Summary
This summary is machine-generated.

Current evidence is insufficient to recommend dietary supplements like selenium, docosahexaenoic acid (DHA), or eicosapentaenoic acid (EPA) for preventing postnatal depression. More research is needed to establish effective and safe prevention strategies for maternal mental health.

More Related Videos

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.0K
Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

26.5K

Related Experiment Videos

Last Updated: May 6, 2026

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
07:05

Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet

Published on: January 3, 2017

9.2K
Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants
06:39

Using a Murine Model of Psychosocial Stress in Pregnancy as a Translationally Relevant Paradigm for Psychiatric Disorders in Mothers and Infants

Published on: June 13, 2021

3.0K
Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents
07:30

Using Chronic Social Stress to Model Postpartum Depression in Lactating Rodents

Published on: June 10, 2013

26.5K

Area of Science:

  • Obstetrics and Gynecology
  • Nutritional Psychiatry
  • Perinatal Mental Health

Background:

  • Postnatal depression (PND) significantly impacts maternal and infant well-being, with limited evidence on safe prevention strategies.
  • Maternal dietary deficiencies during pregnancy and postpartum may contribute to PND.
  • Investigating supplements like omega-3 fatty acids, iron, folate, and vitamins is crucial for potential PND prevention.

Purpose of the Study:

  • To evaluate the efficacy of dietary supplements in preventing postnatal depression.
  • Assess benefits during antenatal, postnatal, or both periods.

Main Methods:

  • Searched the Cochrane Pregnancy and Childbirth Group's Trials Register.
  • Included randomized controlled trials (RCTs) of dietary supplementation versus placebo or standard care.
  • Two independent reviewers assessed trial eligibility, risk of bias, and extracted data.

Main Results:

  • Two RCTs were included: one on selenium and one on omega-3 fatty acids (DHA/EPA).
  • Selenium supplementation showed a non-significant trend towards reducing PND symptoms (P=0.07).
  • DHA and EPA supplementation did not demonstrate significant benefits in preventing PND or related outcomes.

Conclusions:

  • Insufficient evidence exists to support selenium, DHA, or EPA for PND prevention.
  • No current evidence recommends other dietary supplements for PND prevention.
  • Further research is required to identify effective PND prevention strategies.